If this is your first visit, be sure to check out the FAQ in HCMA Announcements. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. Your Participation in this message board is strictly voluntary. Information and comments on the message board do not necessarily reflect the feelings, opinions, or positions of the Hypertrophic Cardiomyopathy Association. At no time should participants to this board substitute information within for individual medical advice. The Hypertrophic Cardiomyopathy Association shall not be liable for any information provided herein. All participants in this board should conduct themselves in a professional and respectful manner. Failure to do so will result in suspension or termination. The moderators of the message board working with the HCMA will be responsible for notifying participants if they have violated the rules of conduct for the board. Moderators or HCMA staff may edit any post to ensure it conforms with the rules of the board or may delete it. This community is welcoming to all those with HCM we ask that you remember each user comes to the board with information and a point of view that may differ from that which you hold, respect is critical, please post respectfully. Thank you

Announcement

Collapse
No announcement yet.

misleading headline...

Collapse

About the Author

Collapse

Lisa Salberg Find out more about Lisa Salberg
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • misleading headline...

    In this weeks Circulation is an article that at first glance appears to be a new option for septal reduction. It is not and in the abstract provided (below) it is clear that this is NOT a good option for those with HOCM.
    Lisa

    Covered Stent Septal Ablation for Hypertrophic Obstruction Cardiomyopathy
    Angelo Anzuini, MD; Barry F. Uretsky, MD
    Division of Cardiology, University of Texas Medical Branch, Galveston, Tex,
    To the Editor:

    Fifer et al1 report a case of hypertrophic obstructive cardiomyopathy in which a covered stent was implanted in the left anterior descending artery to occlude the first septal branch after an unsuccessful attempt to cannulate it. Recurrence of symptoms was associated with collateralization from the right coronary artery of the occluded septal branch. We think this case is of special interest to the interventional cardiologist because it can be analogized to treatment of the complex bifurcation lesion. First, it demonstrates that the myocardium supplied by an occluded side branch during intervention may be protected by a collateral.2 Second, it raises the concern, especially with the use of GpIIb/IIIa inhibitor, that in the rare case of a side branch perforation after percutaneous coronary intervention in a patient in whom the bulky covered stent cannot be implanted in the side branch, covering the main branch may be ineffective in preventing tamponade, specifically because of the collateral, which in this scenario, is clearly not "protective."3,4 Finally, we have a serious concern about the use of a covered stent to treat hypertrophic obstructive cardiomyopathy. There is probably a 20% risk of stent site stenosis, which, in the setting of hypertrophy, might place the patient at high risk for severe and possibly life-threatening ischemia. As such, this type of therapy must be viewed with extreme caution unless scientific data validate this approach.
    Knowledge is power ... Stay informed!
    YOU can make a difference - all you have to do is try!

    Dx age 12 current age 46 and counting!
    lost: 5 family members to HCM (SCD, Stroke, CHF)
    Others diagnosed living with HCM (or gene +) include - daughter, niece, nephew, cousin, sister and many many friends!
    Therapy - ICD (implanted 97, 01, 04 and 11, medication
    Currently not obstructed
    Complications - unnecessary pacemaker and stroke (unrelated to each other)

Today's Birthdays

Collapse

Working...
X